Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-035705
Filing Date
2025-03-07
Accepted
2025-03-07 17:30:14
Documents
98
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tkno-20241231.htm   iXBRL 10-K 2881664
2 EX-19 tkno-ex19.htm EX-19 138105
3 EX-23.1 tkno-ex23_1.htm EX-23.1 3063
4 EX-23.2 tkno-ex23_2.htm EX-23.2 10506
5 EX-31.1 tkno-ex31_1.htm EX-31.1 17640
6 EX-31.2 tkno-ex31_2.htm EX-31.2 17744
7 EX-32.1 tkno-ex32_1.htm EX-32.1 15417
8 EX-97 tkno-ex97.htm EX-97 58529
  Complete submission text file 0000950170-25-035705.txt   12496454

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tkno-20241231.xsd EX-101.SCH 1821727
100 EXTRACTED XBRL INSTANCE DOCUMENT tkno-20241231_htm.xml XML 2156943
Mailing Address 2451 BERT DRIVE HOLLISTER CA 95023
Business Address 2451 BERT DRIVE HOLLISTER CA 95023 8316371100
Alpha Teknova, Inc. (Filer) CIK: 0001850902 (see all company filings)

EIN.: 943368109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40538 | Film No.: 25721373
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)